Related Experiment Video
Updated: Feb 9, 2026
10:14
Using Adeno-associated Virus as a Tool to Study Retinal Barriers in Disease
Published on: April 19, 2015
15.6K
Ultra-Widefield Imaging for Pediatric Retinal Disease
Chetan Kantibhai Patel1, Miranda Buckle2
1Oxford Eye Hospital, Oxford, England.
Summary
This article discusses advancements in retinal imaging, focusing on ultra-widefield technology and its field of view. It details Optomap and Spectralis systems for infant angiography and showcases applications in diagnosis, monitoring, and screening.
Area of Science:
- Ophthalmology
- Medical Imaging
Background:
- Retinal imaging is crucial for diagnosing and monitoring eye conditions.
- Traditional imaging methods have limitations in capturing the peripheral retina.
Purpose of the Study:
- To explore the development and applications of ultra-widefield retinal imaging.
- To detail specific ultra-widefield platforms like Optomap and Spectralis.
Main Methods:
- Review of ultra-widefield imaging technology and its principles.
- Detailed examination of Optomap and Spectralis noncontact imaging systems.
- Inclusion of protocols for infant angiography.
Main Results:
- Ultra-widefield imaging significantly expands the field of view compared to traditional methods.
- Optomap and Spectralis offer advanced capabilities for retinal visualization.
- Case studies demonstrate effective use in diagnosis, monitoring, and screening.
Conclusions:
- Ultra-widefield imaging represents a significant advancement in ophthalmology.
- These technologies enhance the ability to detect and manage peripheral retinal diseases.
- The platforms are valuable tools for both routine care and specialized infant diagnostics.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
266
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
266
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
320
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
320
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
239
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
239
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
305
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
305
01:30Inflammatory Bowel Disease II: Crohn's Disease
1.1K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.1K
01:25Immunodeficiency Diseases
2.4K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
2.4K